Poster Abstract Session:
052. HAI: MDRO-GNR/Emerging Resistant Bacterial Pathogens
Thursday, October 5, 2017: 12:30 PM-2:00 PM
Room: Poster Hall CD

Tracks: Adult ID, Epidemiology and Infection Control, Investigative ID, Pediatric ID


Presentations:
345
Prevalence of Carbapenemase-producing Enterobacteriaceae (CPE) in Hospital Drains and Relationship to Patient Isolates in Toronto, Canada
Alainna Jamal, Hons. BSc; Jennie Johnstone, MD; Kevin Katz, MD, CM, MSc, FRCPC; Allison Mcgeer, MD, MSc; Matthew Muller, MD, PhD; Nadeem Khan, MD; Vita Koren, BSc; Angel Li, MSc; Aimee Paterson, MSc; Renata Souto, PhD; Lin Tang, MBBS, MHA, MSBME, CIC; Cameron Thomas, BSc(c); Wil Ng, MHSc
Posters
  • IDWeek Poster FINAL PDF.pdf (302.1 kB)
  • 346
    Genomic Epidemiology of bla-KPC Klebsiella pneumoniae (KPC-Kp) in a High-Transmission Long-Term Acute Care Hospital (LTACH)
    Shawn E. Hawken, MPH; Karen Lolans, BS; Michael Y. Lin, MD, MPH; Mary K. Hayden, MD; Evan S. Snitkin, Ph.D.
    347
    The importance of ventilator skilled nursing facilities (vSNFs) in the regional epidemiology of carbapenemase-producing organisms (CPOs)
    Michael Y. Lin, MD, MPH; Mary Carl Froilan, RN; Karen Lolans, BS; Pamela Bell, BS; David Wirth, MPH; Sarah K. Kemble, MD; Massimo Pacilli, MS MPH; Stephanie R. Black, MD, MSc; Olufemi Jegede, MPH; Erica Runningdeer, MSN, MPH, RN; Angela S. Tang, MPH; Chinyere Alu, MPH; Rachel Slayton, PhD, MPH; Anthony E. Fiore, MD; John A. Jernigan, MD, MS; William E. Trick, MD; Robert A. Weinstein, MD; Mary K. Hayden, MD
    348
    The MDR Upon Admission Score: Shortening Time to Initiation of Appropriate Antimicrobial Therapy in the Era of Resistance in the Community
    Shani Zilberman-Itskovich, MD; Tsilia Lazarovitch, PhD; Ronit Zaidenstein, M.D.; Mor Dadon, BsC; Chen Daniel, BS; Dror Marchaim, MD
    349
    Carbapenemase Gene Transfer among Canadian Patients Colonized or Infected with Carbapenemase-Producing Enterobacteriaceae
    Nancy Matic, MD; Alex Marchand-Austin, MSc; Emily Borgundvaag, MSc; Allison Mcgeer, MD, MSc; Samir Patel, PhD
    350
    Outbreak Investigation of GES-5 Containing Carbapenem Resistant Enterobacteraceae in a Tertiary Care Hospital
    Abdullah Bukhari, MD; Geoffrey Taylor, MD; Rhoda Wiens, BScN; Stephanie Smith, MD
    Posters
  • 350_IDWPOSTER.pdf (826.0 kB)
  • 351
    Cost Utility of Carbapenemase Producing Enterobacteriaceae (CPE) Screening Strategies in a Low Prevalence Setting
    Rahul Batra, MD; Jonathan Otter, PhD; Jonathan Edgeworth, PhD, MRCP, FRCPath; Simon Goldenberg, MD
    352
    Investigation of Epidemiology and Pathogenesis of Co-infection with Multiple Carbapenem-Resistant Enterobactereciae in Hospitalized Patients
    Thomas Holowka, PhD; Melinda Monteforte, PharmD; Roderick Go, DO; Bennadette Maramara, MD; Teresa Khoo, MD; Robert Chow, MD; Yasin Abul, MD; Rahul Mahapatra, DO; Alexa Morgan, .; Elizabeth Diago-Navarro, PhD; Bettina C. Fries, MD, FIDSA
    353
    Carbapenem-Resistance in Gram-Negative Organisms using a Large US Clinical Database
    Josephine Tran, PharmD, MS; Rui Song, PhD; Adeniyi Togun, MBBS, MPH; Ami Buikema, MPH
    354
    Molecular and Microbiological Evaluation of Carbapenem-resistant Enterobacteriaceae (CRE) at Two Centers in Texas
    Ruth Serrano, MD; Michelle Matheu, MD; Federico Perez, MD, MS; Jan E. Patterson, MD, MS, FIDSA, FSHEA; Steven Dallas, PhD; Susan D. Rudin, BS; Robert A. Bonomo, MD; Kristi Traugott, PharmD, BCPS; Jose Cadena, MD/ID
    Posters
  • CRE ID week PDF.pdf (198.0 kB)
  • 355
    Sensitivity of Different Anatomic Sites for Detection and Duration of Colonization with Carbapenemase-producing Enterobacteriaceae (CPE)
    Emily Borgundvaag, MSc; Amna Faheem, MBBS, MPH; Shumona Shafinaz, MD; Irene Armstrong, MD, MSc; Brenda Coleman, PhD; Karen Green, MSc, RN; Kithsiri Jayasinghe, MSc; Jennie Johnstone, MD, PhD; Kevin Katz, MD, CM, MSc, FRCPC; Philipp Kohler, MD; Allison Mcgeer, MD, MSc; Roberto Melano, PhD; Matthew Muller, MD, PhD; Samir Patel, PhD; Susan Poutanen, MD, MPH, FRCPC; Anu Rebbapragada, PhD; David Richardson, MD; Alicia Sarabia, MD; Andrew E. Simor, MD, FRCPC, FACP; Barbara Willey, ART; Laura Wisely, RT
    356
    Changing Epidemiology of Carbapenem-Resistant Enterobacteriaceae Bloodstream Infections in United States Veterans Affairs Hospitals, 2004-2014
    Nicholas S. Britt, PharmD, MS; Nimish Patel, PharmD, PhD; Emily M. Potter, PharmD; Molly E. Steed, PharmD
    357
    Optimized Beta-Lactam Therapy Improves Survival in Carbapenem Non-Susceptible Gram-Negative Infections
    Lauren K Flynt, PharmD; Rachel M Kenney, PharmD; Michael Veve, PharmD; Jason Pogue, PharmD; Odaliz Abreu-Lanfranco, MD; Susan L Davis, PharmD
    359
    Clinical outcomes of patients with IMP-type carbapenemase-producing Enterobacteriaceae
    Kayoko Hayakawa, MD, PhD; Masahiro Ishikane, MD, PhD; Kazuhisa Mezaki, MT; Yuichi Katanami, MD; Saho Takaya, MD, MSc; Kei Yamamoto, M.D.; Satoshi Kutsuna, MD, PhD; Maki Nagashima, MT; Yuko Sugiki, RN; Norio Ohmagari, MD, MSc, PhD
    360
    Carbapenem-resistant Enterobacteriaceae Associated with High Rates of Clinical Failure Despite Best Available Therapy
    Elise Martin, MD, MS; Daniel Z. Uslan, MD, MS, FIDSA, FSHEA; Zachary A. Rubin, MD; Romney Humphries, PhD
    Posters
  • CRE Poster ID week 2017.pdf (1.6 MB)
  • 361
    Prevalence and Predictors of Infections Due to Carbapenem-Only Susceptible Organisms After Escalation of Antibiotic Therapy in Hospitalized Patients
    Betty Vu, PharmD; Sheila Wang, PharmD, BCPS AQ-ID; Amy Hanson, PharmD, BCPS AQ-ID; Payal Gurnani, PharmD, BCPS, BCCCP; Kimberly Ackerbauer, PharmD, BCPS; Laura Geswein, PharmD, BCOP, BCPS; Spencer Harpe, PharmD, PhD, MPH; Sarah Won, MD, MPH; Christy Varughese, PharmD, BCPS
    362
    Early implementation of active surveillance on detection of carbapenemase-producing Enterobacteriaceae
    Tetsuya Yagi, M.D., Ph.D.; Mitsutaka Iguchi, M.D.; Nobuyuki Tetsuka, M.D.; Hiroshi Morioka, M.D.; Akane Matsumoto, M.D.; Kato Hiroki, M.D.; Yuka Tomita, M.D., Ph.D.
    Posters
  • Poster upload file.pdf (805.9 kB)
  • 363
    Carbapenem-Resistant Enterobacteriaceae (CRE) Bacteremia: Risk Factors for Death at 17 US Centers, 2010-14
    David Kopelman, MD; Madeline Kowalski, BA; Jennifer L. Steinbeck, MD; Nirav Shah, MD, MPH; Rohit Singh, MD; Angella Charnot-Katsikas, MD; Michael Z David, MD PhD
    364
    Minocycline in the Treatment of Carbapenem-Resistant Klebsiella pneumoniae
    Akshay Khatri, MBBS; Stephen Lobo, MD; Rajat Nog, MD; Leslie Lee, PharmD; Guiqing Wang, MD; Abhay Dhand, MD
    365
    Risk Factors Associated with Community-Onset CRE Colonization
    Stephen Blatt, MD; Tamara Bininashvilli, MD; Jenni Steinbrunner, BS, CCRP
    366
    An Evaluation of Meropenem Use and Resistance in a Mixed Medical/Surgical Intensive Care Unit
    Matthew Crotty, PharmD; Tamara Reiter, PharmD, BCPS, BCCCP; Kristen Hillebrand, PharmD, BCCCP; Tung Tran, MD; Edward Dominguez, MD, FACP, FIDSA
    370
    The Epidemiology and Microbiology of Outpatient Carbapenem-Resistant Enterobacteriaceae
    Amanda Durante, PhD, MSc; Meghan Maloney, MPH; David Banach, MD, MPH, MS
    371
    National Prevalence and Regional Variation of Carbapenem-resistant Gram-negative Bacteria in the Ambulatory and Acute Care Settings in the United States in 2016
    Bin Cai, MD, PhD; Roger Echols, MD, FIDSA; Gareth Morgan, Ph.D; David Van Veenhuyzen, MBChB, MPharmMed; Mari Ariyasu, Ph.D; Takuko Sawada, BA; John Murray, MPH; Tsutae Den Nagata, MD, PhD, FFPM; Vikas Gupta, PharmD, BCPS
    372
    Carbapenemase-producing Enterobacteriaceae in Transplanted Patients
    Teresa Sukiennik, MD; Daniela Branco, RN; Claudio Stadnik, MD; Aline Scheibler, RN; Luciana Galo, RN
    373
    Modeling Carbapenem Resistance Among Gram Negative Pathogens Using Commonly Available Clinical Data
    Stefan Richter, MD; James A. McKinnell, MD; Douglas Bell, MD, PhD; Daniel Z. Uslan, MD, MS, FIDSA, FSHEA; Karol Watson, MD; Romney Humphries, PhD; Loren Miller, MD, MPH, FIDSA
    374
    Burden of Carbapenem-resistant Gram-negative Infections in US Hospitals
    Bin Cai, MD, PhD; Roger Echols, MD, FIDSA; Frank Corvino, PhD; Gareth Morgan, Ph.D; David Van Veenhuyzen, MBChB, MPharmMed; Mari Ariyasu, Ph.D; Takuko Sawada, BA; Tsutae Den Nagata, MD, PhD, FFPM
    375
    Global Prevalence of Colistin- and Carbapenem-Resistant Gram-Negative Organisms: SMART 2015-2016
    Sibylle Lob, MD, MPH; Meredith Hackel, PhD, MPH; Robert Badal, BS; Katherine Young, MS; Mary Motyl, PhD; Dan Sahm, PhD
    376
    Attributable Clinical and Economic Burden of Carbapenem Non-susceptible Gram-negative Infections among Patients Hospitalized with Respiratory Infections
    Ying Tabak, PhD; Anita Sung, PhD; Richard Johannes, MD, MS; Gang Ye, PhD; Stephen Kurtz, MS; Latha Vankeepuram, MS; Vikas Gupta, PharmD, BCPS; Eilish McCann, PhD
    377
    Evaluation of Risk Factors for Catheter Related Urinary Tract Infections caused by Carbapenem Resistant Klebsiella pneumonia
    Cigdem Ataman Hatipoglu, Assoc. Prof.; Cemal Bulut, Prof.; Sebnem Erdinc, Assoc. Prof.; Gunay Ertem, Assoc. Prof.; Sami Kinikli, MD; Necla Tulek, Prof.; Bedia Dinc, Assoc. Prof.; Esra Kaya Kilic, MD. PhD.; Meliha Cagla Sonmezer, MD
    378
    Surveillance Screening for Extended-Spectrum Beta-Lactamases in Skilled Nursing Facility Admissions
    Andrew Skinner, MD; Shane Zelencik, MPH, CIC; Lance Peterson, MD, FIDSA, FSHEA
    380
    Risk Factors for Colonization or Infection with Cefepime Resistant, Piperacillin-Tazobactam Susceptible Gram-Negative Bacilli
    Janet Wu, PharmD; Ryan Mynatt, PharmD; Keith S. Kaye, MD, MPH; Jason M. Pogue, PharmD
    382
    Comparison of epidemiology of IMP-type metallo-beta-lactamase producing carbapenem-resistant Klebsiella pneumoniae vs Enterobacter cloacae in a tertiary care hospital in Japan over 5 years
    Masahiro Ishikane, MD, PhD; Kayoko Hayakawa, MD, PhD; Kazuhisa Mezaki, MT; Yuichi Katanami, MD; Saho Takaya, MD, MSc; Maki Nagashima, MT; Yuko Sugiki, RN; Norio Ohmagari, MD, MSc, PhD
    383
    Mcr-1 in Connecticut: Investigations of an Emerging Resistance Gene in Two Patients, 2016–2017
    Vivian Leung, MD; Noelisa Montero, MPH; Meghan Maloney, MPH; Amber Vasquez, MD, MPH; Mark Laughlin, DVM, MPH; Ehren Dancy, MD; Russell Melmed, MPH; Jessica Chen, PhD; Jason Folster, PhD; Rebecca Lindsey, PhD; David Lonsway, MMSc; Sandra Boyd, BS; Louise Francois Watkins, MD, MPH; Maroya Spalding Walters, PhD, ScM; Lynn Sosa, MD
    384
    Identification of Three Patients with Colistin Resistant Escherichia coli Isolates Containing the mcr-1 (Mobile Colistin Resistance) Gene from a Single Health System in Michigan, USA
    Laraine L. Washer, MD; Brenda Brennan, MSPH; John Mills, MD; Carolyn Dombecki, MPH, CIC; Amanda Valyko, MPH, CIC; Oryan Henig, MD; Marty Soehnlen, PhD, MPH; Kelly Jones, BS, MT, ASCP; Keith S. Kaye, MD, MPH; Michael A. Bachman, MD, PhD
    Posters
  • ID week mcr-1 poster final.pdf (702.3 kB)
  • 385
    Clinical and Microbiological Characteristics of Colistin-Resistant Enterobacteriaceae at a Large Tertiary Care Center in Michigan
    John P. Mills, MD; Oryan Henig, MD; Twisha Patel, PharmD; Laraine L. Washer, MD; Michael A. Bachman, MD, PhD; Carey Dombecki, MPH; Keith S. Kaye, MD, MPH
    386
    Risk Factors for Colistin Resistance; A 10 Year Experience at a Tertiary Medical Center
    Stefan Richter, MD; James A. Mckinnell, MD; Douglas Bell, MD, PhD; Daniel Z. Uslan, MD, MS, FIDSA, FSHEA; Karol Watson, MD; Loren Miller, MD, MPH, FIDSA; Romney Humphries, PhD
    387
    Intestinal Colonization with Escherichia coli Sequence Type 131 (ST131) and Other Fluoroquinolone (FQ)-Resistant E. coli (FQREC) within Households (HHs) of Veterans
    Muhanad Mohamed, MD; Connie Clabots, BS MT(ASCP); Stephen B. Porter, MS; Paul Thuras, PhD; James R. Johnson, MD
    388
    Longitudinal Analysis of ICU Surface Multidrug Resistant Organism Contamination in the US and Pakistan
    Jennie H. Kwon, DO, MSCI; Alaric D' Souza, BS; Robert Potter, BS; Meghan Wallace, BS; Angela Shupe, BS; Sanket Patel, MS; Danish Gul, BS; Saadia Andleeb, PhD; Carey-Ann D. Burnham, PhD; Gautam Dantas, PhD
    389
    EVALUATION OF THE MANAGEMENT OF ESBL PRODUCING ENTEROBACTERIACEAE INFECTIONS: CHI HEALTH OMAHA
    Scott Shipley, Pharm. D.; Stephen Cavalieri, Ph.D.; Renuga Vivekanandan, MD; Christopher Destache, PharmD
    Posters
  • IDWeek-17.pdf (925.1 kB)
  • 390
    Enhanced Gram Negative Resistance Gene Survelliance in Clinical Samples using a Rapid Microarray System
    Rahul Batra, MD; Alex Natale, PhD; Jonathan Otter, PhD; Jonathan Edgeworth, PhD, MRCP, FRCPath
    391
    Discordant Ertapenem/Imipenem Susceptibilities in Enterobacter bacteremia: Frequency and Outcomes
    Andrew Chou, MD; Haley Pritchard, MD; Richard Sucgang, PhD; Lynn Zechiedrich, PhD
    392
    Trends in the incidence of bacteremia with carbapenem non-susceptible Acinetobacter spp. in patients from the US Veterans Health Administration, 2000-2015.
    Sachin Patel, MD; Brigid Wilson, PhD; Nadim G. El Chakhtoura, MD; Elie Saade, MD, MPH; Curtis J. Donskey, MD; Robert A. Bonomo, MD; Federico Perez, MD, MS
    394
    Gram-negative bacilli in critically ill burn patients
    Shannon Williams, BS anticipated; Melissa Miller, PhD; David Van Duin, MD, PhD; Shannon Carson, MD; Bruce Cairns, MD; Anne Lachiewicz, MD, MPH
    395
    Risk Factors for Death from Carbapenem-Resistant Acinetobacter baumannii (CRAb) Bacteremia at 12 US Medical Centers, 2010-14
    David Kopelman, MD; Madeline Kowalski, BA; Jennifer L. Steinbeck, MD; Nirav Shah, MD, MPH; Angella Charnot-Katsikas, MD; Michael Z David, MD PhD
    401
    Characteristics and Predictive Factors for Multidrug-Resistant Gram-Negative Infection Following Deployment-Related Trauma
    Wesley Campbell, MD; Ping Li, MS; Leigh Carson, MS; Timothy J. Whitman, DO; Dana M. Blyth, MD; Joseph L. Petfield, MD; Katrin Mende, PhD; David R. Tribble, MD, DrPH, FIDSA
    403
    Clinical Characteristics and Resistance Patterns of Pseudomonas aeruginosa isolated from Operations Enduring Freedom and Iraqi Freedom Trauma Patients
    Mary Ford, MD; Katrin Mende, PhD; Susan J. Kaiser, BS; Miriam L. Beckius, MPH; Dan Z. Lu, MS; David R. Tribble, MD, DrPH; Dana M. Blyth, MD
    404
    Current Antimicrobial Resistant Prevalence by Hospital Characteristics: Analysis of Microbiological Data from October 2016 to March 2017 in 339 US Hospitals
    Ying Tabak, PhD; Vikas Gupta, PharmD, BCPS; Richard Johannes, MD, MS; Stephen Kurtz, MS; John Murray, MPH; Patrick Murray, PhD
    405
    Changing Trends in Antimicrobial Resistance Pattern in Klebsiella species Bacteremia in an Out-patient Hemodialysis Unit over 6 Years (2010-2015) in a Tertiary Care Hospital in Pakistan
    Sunil Dodani, MBBS;FCPS(Medicine);FCPS(Infectious Diseases);FACP; Asma Nasim, MBBS; FCPS (Medicine); FCPS (Infectious Diseases)
    407
    Impact of Screening/Decolonization Program on Carbapenem-Resistant Enterobacteriaceae (CRE) and Methicillin-Resistant Staphylococcus aureus (MRSA) Colonized Patients and their Subsequent Risk for Infections
    Juan Diego Velez, MD; Fernando Rosso, MD, MSc; Ana Milena Ruiz, MD; Marly Orrego, RN, MSC; Nora Guarin, Pathology; Sofia Montes, Medical Student; Andres Lindo, Medical Student; Eric Tafur, Medical Student
    408
    Sustainability of Vancomycin Resistant Enterococci (VRE) Control: Collateral Effects of Hospital-wide Carbapenem Resistant Enterobacteriaceae (CRE) Control Program
    Pasri Maharom, MD, MPH; Sorapop Pakdeewongse, M.D.; Thammasin Inviya, MD; Aungsumalin Sricharoon, BNS; Kaimuk Thongyen, BNS; Kasama Canchanapan, M.S. (Clinical Pharmacy); Saisamorn Charoengampit, MS (Clinical Pharmacy); Chirapan Tantimongkolsuk, MD
    Posters
  • IDweek2017.pdf (697.8 kB)
  • 409
    Multi-drug Resistant Organisms (MDROs) Have Escaped the Hospital: Evidence of Community Acquisition at a Regional Hospital
    Nicholas Turner, MD; Rebekah W. Moehring, MD, MPH; Vance G. Fowler Jr., MD; Kenneth Schmader, MD; David J. Weber, MD, MPH; Daniel J. Sexton, MD, FIDSA, FSHEA; Deverick J. Anderson, MD, MPH, FIDSA, FSHEA
    410
    Active Surveillance for Carbapenem-resistant Enterobacteriaceae, Vancomycin-resistant Enterococci and toxigenic Clostridium difficile among Patients transferred from Long-term Care Facilities at a Tertiary Hospital in Korea
    Joo-Hee Hwang, MD; Jeong Su Park, MD; Eunyoung Lee, M.D.; Pyeong Gyun Choe, M.D.; Wan Beom Park, MD; Ji Hwan Bang, MD, PhD; Sang Won Park, M.D., Ph.D.; Nam Joong Kim, MD, PhD; Myoung-Don Oh, M.D., Ph.D.; Kyoung-Ho Song, MD; Eu Suk Kim, MD; Hong Bin Kim, MD, PhD

    CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.